Is cardiomyocyte maturation an obstacle in your research?
You’re not alone. Many groups are using electrical pacing, 3-D microtissues with mechanical stimulation, or very long culture periods to achieve some degree of maturation.
Luckily, StemBiosys has the solution. When iPSC-derived cardiomyocytes are seeded onto CELLvo™ Matrix Plus, they spontaneously align and become structurally mature…in just 7 days!
And now, you can obtain CELLvo™ Matrix Plus and iPSC-derived cardiomyocytes grown in the matrix with 15% off!
Offer Details
Get 15% off CELLvo Matrix Plus, iPSC-derived cardiomyocytes, and related kits for a limited only!
You can claim this offer by mentioning promo code ‘CELLvo15’ when contacting us.
Offer valid until 31st October 2024.
About StemBiosys’s CELLvo Matrix and cardiomyocytes
CELLvo™ Matrix Plus is the next generation of CELLvo™ Matrix technology. CELLvo™ matrices are the only substrates that aim to recapitulate biochemical as well as structural and mechanical cues of the native niche by leaving the extracellular matrix intact. Cell-derived matrices create a biologically relevant culture environment for a variety of cell types by providing all the cues cells expect to receive in vivo in StemBioSys® culture dishes. This means that instead of responding to foreign culture conditions, cells respond to your experimental variables.
Initially developed for pluripotent stem cell culture, Stembiosys® has subsequently discovered that CELLvo™ Matrix Plus is the ideal substrate for cardiomyocyte maturation and culture.
Commercially available iPSC-derived cardiomyocytes seeded onto CELLvo™ Matrix Plus rapidly and spontaneously align and become structurally mature. Within 7 days of seeding on CELLvo™ Matrix Plus, a large percentage of commercially available iPSC-derived cardiomyocytes become rod-shaped and bi-nucleated. These are markers of maturation seldom seen using traditional methods.
About StemBiosys
What started as a project by Dr. Xiao-Dong Cheng, a tenured professor at UT Health San Antonio, to solve the loss of stem cell properties of mesenchymal stem cells (MSCs) during cell culture, culminated in the development of CELLvo™ Matrix. This advanced stem cell culture system replicates the 3-dimensional environment where stem cells naturally reside and proliferate and has now become a platform technology that supports other scientists in stem cell research.
Since then, StemBioSys has been innovating the field of regenerative medicine by expanding its line of high-quality cells and cell expansion tools.
Caltag Medsystems distributes StemBiosys‘s products in the UK and Ireland.